MSI2 and triple-negative breast carcinoma: This is in line with findings in lung cancer implicating MSI2 in DNA damage repair (Qu et al., 2024; Barber et al., 2025) and in triple-negative breast cancer regarding double knockdown of MSI1 and MSI2 (Troschel et al., 2020).